...
首页> 外文期刊>Archives of pharmacal research >Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats
【24h】

Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats

机译:胃滞留形式的依卡贝特钠对大鼠胃溃疡的治疗作用

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of the present study is to investigate the influence of gastric retention of ecabet sodium (ECS) on its mucoprotective effect in rat ulcer models. Mini-tablets containing 9 mg ECS were prepared using the direct compression method. The release rates of ECS mini-tablets were controlled by the amount and viscosity grade of hydroxypropylmethyl cellulose incorporated. Gastric retention of ECS mini-tablets after oral administration to rats was visually confirmed using a fluorescence imaging system. Because ECS mini-tablets exhibited size-dependent gastric retention, their gastric retention time was prolonged as the release rate decreased. In the in vivo efficacy study, gastro-retentive dosage forms of ECS did not influence the mucoprotective effect in the immediate irritation model but enhanced the effect in the delayed irritation model compared with ECS suspension. This finding indicates that the duration of the mucoprotective effect of ECS can be extended by the employment of gastro-retentive dosage formulations and provides a rationale for development of ECS gastro-retentive dosage forms.
机译:本研究的目的是研究在大鼠溃疡模型中胃retention留依卡贝酸钠(ECS)对其黏膜保护作用的影响。使用直接压片法制备含有9毫克ECS的迷你片剂。 ECS微型片剂的释放速率由所掺入的羟丙基甲基纤维素的量和粘度等级控制。使用荧光成像系统从视觉上证实了大鼠口服给药后ECS小片的胃保留。由于ECS小型片剂表现出大小依赖性的胃gastric留,其胃retention留时间会随着释放速率的降低而延长。在体内功效研究中,ECS的胃滞留剂型不影响即时刺激模型中的粘膜保护作用,但与ECS悬浮液相比,增强了延迟刺激模型中的粘膜保护作用。该发现表明,通过使用胃滞留剂型可以延长ECS的粘膜保护作用的持续时间,并且为开发ECS胃滞留剂型提供了原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号